ML
Martin Lehr
View Martin's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
2015 - Present · 9 years and 11 months
Praesidia Biologics
N/A
Nov 2020 - Present · 4 years and 1 months
N/A
May 2019 - Present · 5 years and 7 months
Company Details
2-10 Employees
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
2001 Market Street
Suite 3915, Unit 15
Philadelphia, Pennsylvania 19103, US
Keywords
Oncology and Bispecific Antibody
Contact Details
- Email AddressM**@contexttherapeutics.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Martin Lehr in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.